World Sleep Industry ENCYCLOPEDIA

Sleep Data Synthesis Processing

6.4.2

Definition, Types, and Uses

Sleep-data synthesis processing uses statistical models, machine learning, signal simulation, or rule systems to create new records that approximate selected structures, distributions, and relationships in real sleep data. Fully synthetic data replaces every person-level field. Partially synthetic data replaces only selected variables and may retain real ages, diagnoses, or events. Simulated data may come from physiological or device models and need not be trained on real participant records. These categories have different privacy properties, fidelity, and valid uses and should not be treated as interchangeable.

Synthetic data can support software development, interface testing, training demonstrations, analytical prototypes, exploratory research, algorithm pretraining, augmentation of limited scenarios, and constrained data sharing. It can reduce the need for real personal data in selected stages, but it is not anonymous by default and should not replace real-world evidence without validation. A service must label the generation purpose, source scope, synthesized and retained fields, target population, permitted uses, and prohibited uses. A dataset made for testing does not support clinical conclusions merely because its format looks realistic.

Source Data, Generation Process, and Lineage

Generation should begin with source data that is lawfully used, suitable, and representative of the intended population. Documentation should cover acquisition devices, sleep centers, time period, inclusion and exclusion rules, labeling, missingness, preprocessing, and sample splits. PSG, EEG, ECG, breathing, oxygen saturation, movement, environmental audio, bedroom video, questionnaires, and diagnosis labels have different sampling rates and dependency structures. If alignment or segmentation is wrong before synthesis, the generator will reproduce and amplify the defect. Bias, device artifacts, and label errors in the source do not disappear when the output is called synthetic.

Development, validation, and held-out test data should be separated before training so the same real record is not used to tune and evaluate the generator. Generator version, random-seed management, hyperparameters, epochs, feature engineering, conditions, stopping criteria, and post-processing need traceable lineage. Multiple nights must be split by person so adjacent nights do not cross training and testing, and long waveform segments must retain person, night, and channel grouping. A partially synthetic file needs field-level labels for real, derived, and synthetic status so a user cannot mistake retained values for artificial ones.

Privacy Risks and Protective Mechanisms

A generator may memorize and reproduce training examples, especially rare conditions, unusual waveforms, distinctive time series, or records from small groups. An attacker may compare nearest neighbors, infer whether a person was in training, derive an unknown attribute from known ones, or link a synthetic record to external information. The absence of a real name on a synthetic row does not rule out disclosure about a source person. Privacy evaluation should cover exact and approximate copying, nearest-neighbor distance, membership inference, attribute inference, unique combinations, outliers, and composition across releases under realistic auxiliary knowledge.

When a robust, quantifiable source-data guarantee is required, a differentially private training or generation algorithm should be considered, with disclosure of the privacy unit, adjacency, contribution bounds, epsilon, delta, and cumulative budget. A non-differentially private generator can provide empirical evidence only against the tested attacks and cannot promise resistance to unknown attacks. Removing apparent duplicates, filtering by distance, or suppressing small groups may reduce selected risks but does not create a general proof. Source data, model weights, checkpoints, random state, and generation logs remain sensitive assets.

Fidelity, Statistical Utility, and Bias

Fidelity assessment should move beyond individual variables to joint distributions, temporal structure, and clinical relationships. In addition to means, variances, quantiles, and category proportions, evaluation should compare sleep-stage transitions, cycle length, event duration, cross-channel synchrony, daily or night-to-night change, and conditional distributions by age, sex, device, and disorder. Similar marginal histograms can coexist with broken relationships between respiratory events and desaturation, sleep stage and arousal, or movement and heart rate. Similarity is not proof of correct provenance, and exceptional closeness may instead indicate memorization.

Synthesis introduces modeling, sampling, and random error and may erase rare events, invent impossible combinations, or reinforce source bias. Acceptance criteria should define use-specific metrics, tolerances, and failure rules in advance and report overall performance, small groups, extremes, and missingness separately. Physiological rule checks should detect negative durations, invalid stage sequences, implausible sampling rates, and contradictory labels. A single aggregate score must not conceal distinct privacy and utility dimensions, and metrics should not be selected for favorable results before the intended use is stated.

Downstream Task and Clinical Validation

The value of synthetic data should be tested through the target task. Software testing should examine schema coverage, boundary values, error messages, format consistency, and defect detection. Statistical use should compare estimates, confidence intervals, and direction of conclusions against a real held-out set. Machine-learning evaluation can train on synthetic data and test on real data that was never used for generation, then compare discrimination, calibration, robustness, and subgroup performance with a real-data training baseline. Cross-validation entirely within synthetic data cannot demonstrate generalization to real patients and devices.

Synthetic data may augment rare scenarios, but it cannot establish their true prevalence or clinical diversity from nothing. Oversampling rare respiratory events, pediatric cases, or comorbid populations should distinguish educational coverage from epidemiological representation and guard against near-copying the few real cases. For diagnosis, treatment, device performance, or regulatory evidence, the role of synthetic evidence must be explicit, sufficient independent real data must confirm performance, and sleep medicine, statistical, and engineering experts should review the result. A plausible generative model cannot substitute for clinical validity.

Release, Operations, and Auditability

Public release, controlled research access, internal testing, and vendor exchange require different risk thresholds. Before release, the dataset and generator version should be frozen and pass separate privacy and utility reviews, with the approved scope, recipients, license, prohibited linkage, and redistribution terms recorded. High-risk data may still require a secure environment, query interface, download restrictions, or data-use agreement after evaluation. Multiple synthetic versions derived from one source should be assessed together because comparisons may recover stable details or reduce the effect of randomness.

The production pipeline needs controls for code, dependencies, model weights, randomness, keys, temporary files, and access logs. Each dataset should carry machine-readable generation date, version, schema, field meaning, real or synthetic status, intended uses, known limitations, and evaluation-report identifier. The audit trail should connect source approval, training job, parameters, checkpoints, filtering, privacy testing, utility testing, release, and withdrawal. When copying, disclosure, or serious bias is discovered, operators must be able to suspend downloads, notify recipients, withdraw a version, and assess downstream models rather than merely replace the file.

Governance, Procurement, and Service Boundaries

The data controller, privacy lead, data science team, clinical experts, platform operator, and users should jointly decide whether synthesis is suitable for the purpose. Training a generator on source records remains data processing and requires a lawful basis, minimization, access restriction, retention, and arrangements for data-subject rights. The legal status of synthetic data should be evaluated from identifiability risk, retained fields, and the recipient environment rather than a vendor label. Synthesis also does not automatically resolve bias, intellectual property, consent scope, or cross-border processing.

A buyer should require the generation method, source-data profile, full or partial synthesis statement, field-level lineage, privacy model and parameters, memorization and inference tests, utility and subgroup reports, randomness controls, version management, known limitations, independent evaluation, and incident response. Acceptance should retest representative sleep tasks using an independent real held-out set and examine reproduced samples, rare groups, temporal consistency, and cross-version risk. Claims that fake data has zero risk, statistical similarity is sufficient for clinical use, or more generated rows create more truthful information should be replaced by evidence-based, purpose-limited commitments with residual risk.